Berberine
La berberina reduce los niveles de azúcar en sangre y mejora la sensibilidad a la insulina en personas con diabetes y prediabetes
Chromium picolinate
El picolinato de cromo mejora la función de la insulina y ayuda a regular el metabolismo de la glucosa en sangre
Resumen de Efectividad y Riesgos
Condición | Efectividad | Detalles |
|---|---|---|
| Type 2 Diabetes | Robust RCTs show berberine lowers HbA1c ~0.5% and fasting glucose; chromium improves insulin sensitivity; combined yields additive glucose control surpassing each alone. | |
| Metabolic Syndrome | Clinical trials demonstrate combined supplementation improves fasting glucose, triglycerides, and blood pressure, addressing core MetS criteria. | |
| Insulin Resistance | Meta‑analyses report chromium picolinate reduces HOMA‑IR modestly, berberine activates AMPK; together significantly improves cellular insulin response. | |
| Polycystic Ovary Syndrome (PCOS) | PCOS patients with insulin resistance benefit from berberine and chromium, showing reduced androgen levels and improved ovulatory function in RCTs. | |
| Obesity / Weight Management | Combined agents enhance glucose utilization and satiety, leading to modest (~3‑5%) body weight reduction in overweight adults over 12 weeks. |
